CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director of
CMP
CMP
CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director of
a major subsidiary
CIPLA MEDPRO SOUTH AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Company")
DEALING IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information relates to the dealing in securities by a director of a
major subsidiary of Cipla Medpro:
Director: Mr JB van Staden
Status: Executive director of a major subsidiary
Office held: Director of a major subsidiary, Medpro
Pharmaceutica (Pty) Ltd
Date of transaction: 24 November 2011
Nature of transaction: Sale of shares
Number of shares: 60 000
Price per share: R6.55
Total value of transaction: R393 000.00
Extent of interest: Direct, beneficial
Nature of transaction: Sale of shares on the open market
Written clearance to deal obtained: Yes
Durban
28 November 2011
Sponsor
Nedbank Capital
Date: 28/11/2011 17:00:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
